This inventor holds 1 USPTO granted patent. Top assignee: Orchid Research Laboratories Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Lakshmanan Manikandan: Innovator in Heterocyclic Compounds
Introduction
Lakshmanan Manikandan is a notable inventor based in Chennai, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target critical pathways in disease treatment.
Latest Patents
Lakshmanan holds a patent for "Heterocyclic compounds as pSTAT3/IL-6 inhibitors." This invention relates to novel heterocyclic compounds of the general formula (I), which serve as IL-6 inhibitors. The patent encompasses their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, compositions, metabolites, and prodrugs. The invention also provides a method for treating cancer, cancer cachexia, and inflammatory diseases, particularly those mediated by cytokines such as IL-6, through pSTAT3 inhibition in mammals.
Career Highlights
Lakshmanan is associated with Orchid Research Laboratories Limited, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for complex medical challenges.
Collaborations
He collaborates with esteemed colleagues, including Siripragada Mahender Rao and Akella Satya Surya Visweswara Srinvas, to enhance the impact of his research.
Conclusion
Lakshmanan Manikandan's contributions to the field of medicinal chemistry through his innovative patent demonstrate his commitment to advancing healthcare solutions. His work is poised to make a significant impact on the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile